NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Dobler CC, Morrow AS, Farah MH, et al. Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD: A Systematic Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2019 Oct. (Comparative Effectiveness Review, No. 221.)
Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD: A Systematic Review [Internet].
Show detailsTable H.44KQ4: Adverse events. Inhaled Budesonide 40mg compared with Intravenous Methylprednisolone (initially intravenous, then oral)
| Outcome | Finding | Study Design |
|---|---|---|
| Endocrine AE | Rate Ratio: 0.28; 95% CI: 0.14 to 0.57, I2=N/A | 1 RCT73 |
| Total number of AEs | Rate Ratio: 0.28; 95% CI: 0.14 to 0.57, I2 = N/A | 1 RCT 73 |
AE = adverse event; CI = confidence interval; N/A = not applicable; RCT = randomized controlled trial
- Table H.44, KQ4: Adverse events. Inhaled Budesonide 40mg compared with Intraveno...Table H.44, KQ4: Adverse events. Inhaled Budesonide 40mg compared with Intravenous Methylprednisolone (initially intravenous, then oral) - Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD: A Systematic Review
Your browsing activity is empty.
Activity recording is turned off.
See more...